- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT07584200
Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip Arthroplasty (THA)
Comparison of the Efficacy and Safety of Three Regional Anesthesia Strategies in Patients Undergoing Elective Total Hip Arthroplasty: A Prospective, Randomized, Multicenter Clinical Trial
The goal of this clinical trial is to learn which of three regional anesthesia approaches provides better pain relief and safety for older adults having planned hip replacement surgery. Researchers will study people aged 60 years and older who are scheduled for elective total hip arthroplasty.
The main questions this study aims to answer are:
Which anesthesia method provides better pain control after surgery? Which method reduces the need for opioid pain medicines? Are there differences in side effects and recovery between the approaches? Participants will be randomly assigned to one of three groups. All participants will receive spinal anesthesia. One group will receive spinal anesthesia with intrathecal morphine. The other two groups will receive spinal anesthesia combined with a nerve block called the pericapsular nerve group (PENG) block, with or without the addition of dexamethasone.
Participants will have their pain levels measured at regular times during the first two days after surgery. Researchers will also record opioid use, time to first pain medication, ability to move after surgery, length of hospital stay, and any side effects such as nausea or itching. Blood tests will be used to measure markers of inflammation.
The results of this study may help doctors choose safer and more effective pain control strategies for people undergoing hip replacement surgery.
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Részletes leírás
Postoperative pain after total hip arthroplasty is associated with increased opioid use, delayed mobilization, and a higher risk of adverse events, particularly in older adults. Spinal anesthesia with intrathecal morphine is widely used to improve postoperative analgesia; however, it may be associated with opioid-related side effects such as nausea, pruritus, urinary retention, and respiratory depression. Ultrasound-guided regional nerve blocks, including the pericapsular nerve group (PENG) block, have emerged as opioid-sparing alternatives that may provide effective analgesia while preserving motor function.
This prospective, randomized, multicenter clinical trial is designed to compare the efficacy and safety of three regional anesthesia strategies in patients undergoing elective total hip arthroplasty. Participants aged 60 years and older will be randomly assigned in a 1:1:1 ratio to one of three study groups: spinal anesthesia with intrathecal morphine; spinal anesthesia combined with a PENG block; or spinal anesthesia combined with a PENG block using perineural dexamethasone as an adjuvant.
All participants will receive standardized spinal anesthesia with ropivacaine. In the control group, intrathecal morphine will be administered as part of routine spinal anesthesia. In the intervention groups, the PENG block will be performed under ultrasound guidance using ropivacaine, with or without the addition of dexamethasone. Perioperative care, postoperative analgesic protocols, and rehabilitation pathways will be standardized across all study centers to minimize variability.
The primary outcome is total postoperative opioid consumption during the first 48 hours after surgery, expressed as intravenous morphine equivalents. Secondary outcomes include pain intensity at rest and during movement assessed using the Numeric Rating Scale (NRS) at 6, 12, 24, and 48 hours after surgery, time to first rescue analgesia, early mobilization, length of hospital stay, and incidence of opioid-related adverse events.
The results of this study will provide comparative evidence on opioid-based versus opioid-sparing regional anesthesia strategies for hip arthroplasty and may help inform clinical decision-making aimed at improving postoperative pain control, functional recovery, and safety in older surgical patients.
Tanulmány típusa
Beiratkozás (Becsült)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
- Név: Malgorzata Reysenr, MD PhD
- Telefonszám: 608762068
- E-mail: mreysner@ump.edu.pl
Tanulmányozza a kapcsolattartók biztonsági mentését
- Név: Malgorzata Reysner, MD PhD
- Telefonszám: 608762068
- E-mail: mreysner@ump.edu.pl
Tanulmányi helyek
-
-
-
Poznan, Lengyelország, 62-701
- Toborzás
- Poznan University of Medical Sciences
-
Kapcsolatba lépni:
- Malgorzata Reysner, M.D. Ph.D.
- Telefonszám: +48 61 873 83 03
- E-mail: mreysner@ump.edu.pl
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Adults aged 60 to 100 years
- Scheduled for elective total hip arthroplasty
- American Society of Anesthesiologists (ASA) physical status I-III
- Ability to understand the study procedures and provide written informed consent
Exclusion Criteria:
- Known allergy or hypersensitivity to ropivacaine, morphine, or dexamethasone
- Coagulation disorders or ongoing anticoagulant therapy contraindicating spinal anesthesia or regional nerve blocks
- Infection at the site of spinal or peripheral nerve block injection
- Pre-existing neurological disorders affecting sensory or motor function
- Severe hepatic or renal insufficiency
- Chronic opioid use for more than 3 months prior to surgery
- Refusal or inability to provide informed consent
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Aktív összehasonlító: Spinal Anesthesia With Intrathecal Morphine
Participants will receive spinal anesthesia with intrathecal ropivacaine combined with intrathecal morphine. Ropivacaine 0.5% (10-15 mg) will be administered intrathecally, followed by intrathecal morphine at a dose of 100 micrograms as part of standard anesthesia care. |
Intrathecal morphine administered as part of spinal anesthesia for postoperative pain control during elective total hip arthroplasty.
Más nevek:
|
|
Kísérleti: Spinal Anesthesia Plus PENG Block
Participants will receive spinal anesthesia with intrathecal ropivacaine 0.5% (10-15 mg) combined with an ultrasound-guided pericapsular nerve group (PENG) block. The PENG block will be performed using 20 mL of ropivacaine 0.2% administered as a single injection. |
Ultrasound-guided pericapsular nerve group block performed as an adjunct to spinal anesthesia to provide postoperative analgesia.
Más nevek:
|
|
Kísérleti: Spinal Anesthesia Plus PENG Block With Dexamethasone
Participants will receive spinal anesthesia with intrathecal ropivacaine 0.5% (10-15 mg) combined with an ultrasound-guided pericapsular nerve group (PENG) block. The PENG block will be performed using 20 mL of ropivacaine 0.2% with the addition of dexamethasone 4 mg administered perineurally as a single injection. |
Perineural dexamethasone administered as an adjuvant to the pericapsular nerve group block to prolong postoperative analgesia.
Más nevek:
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Total Postoperative Opioid Consumption
Időkeret: Up to 48 hours after surgery
|
Total amount of opioids administered postoperatively, expressed as intravenous morphine equivalents. |
Up to 48 hours after surgery
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Pain scores at rest
Időkeret: 6 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
6 hours after surgery
|
|
Pain scores durring movement
Időkeret: 6 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
6 hours after surgery
|
|
Pain scores at rest
Időkeret: 12 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
12 hours after surgery
|
|
Pain scores durring movement
Időkeret: 12 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
12 hours after surgery
|
|
Pain scores at rest
Időkeret: 24 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
24 hours after surgery
|
|
Pain scores durring movement
Időkeret: 24 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
24 hours after surgery
|
|
Pain scores at rest
Időkeret: 48 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
48 hours after surgery
|
|
Pain scores durring movement
Időkeret: 48 hours after surgery
|
Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("the worst pain imaginable")- at rest and during mobilization |
48 hours after surgery
|
|
Time to First Rescue Analgesia
Időkeret: Up to 48 hours after surgery.
|
Time from the end of surgery to the first request for rescue analgesic medication. |
Up to 48 hours after surgery.
|
|
Early Mobilization
Időkeret: Up to 48 hours after surgery
|
Time to first mobilization assessed using the Timed Up and Go test. |
Up to 48 hours after surgery
|
|
Incidence of Opioid-Related Adverse Events
Időkeret: Up to 48 hours after surgery.
|
Occurrence of opioid-related adverse events, including nausea, vomiting, pruritus, and urinary retention. |
Up to 48 hours after surgery.
|
|
Length of Hospital Stay
Időkeret: measured at the day of the discharge from the hospital
|
Total duration of postoperative hospitalization measured in days. |
measured at the day of the discharge from the hospital
|
Együttműködők és nyomozók
Nyomozók
- Tanulmányi szék: Malgorzata Reysner, MD PhD, Poznań University of Medical Sciences
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Becsült)
A tanulmány befejezése (Becsült)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
- Mozgásszervi betegségek
- Ízületi gyulladás
- Ízületi betegségek
- Reumás betegségek
- Osteoarthritis
- Osteoarthritis, csípő
- Heterociklusos vegyületek
- Heterociklusos vegyületek, olvasztott gyűrű
- Alkaloidok
- Policiklusos aromás szénhidrogének
- Policiklusos vegyületek
- Terhesség
- Terhesség
- Szteroidok
- Olvasztott gyűrűs vegyületek
- Szteroidok, fluortartalmú
- Remoklóriumok
- Heterociklusos vegyületek, vagy több gyűrű
- Morfinánok
- Opiát alkaloidok
- Heterociklusos vegyületek, áthidaló gyűrű
- Fenanthrenes
- Morfinszármazékok
- Dexametazon
- Morfin
Egyéb vizsgálati azonosító számok
- 1/2026
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .